Clinical Trial Update: Trimetazidine Therapy in Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating trimetazidine as a therapy for hypertrophic cardiomyopathy; the current status is Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: University College, London | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: UNKNOWN